CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic Lymphoma, a Two-Institution Experience
Chun Li, Zhi-Jun Wuxiao, Xiaoqin Chen, Guanjun Chen, Yue Lu, Zhongjun Xia, Yang Liang, Hua Wang
Cancer Research and Treatment. 2020;52(2):573-585.   Published online 2019 December 6    DOI: https://doi.org/10.4143/crt.2019.542

Excel Download

A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic Lymphoma, a Two-Institution Experience
Cancer Research and Treatment. 2020;52(2):573-585   Crossref logo
Link1 Link2 Link3

Experience with provisional WHO-entities large B-cell lymphoma with IRF4 -rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group
British Journal of Haematology. 2020;   Crossref logo
Link1 Link2

Feasibility and Outcome of the Hyper-CVAD Regimen in Patients With Adult Acute Lymphoblastic Leukemia
Clinical Lymphoma Myeloma and Leukemia. 2015;15(1):52-57   Crossref logo
Link1 Link2

The French ACVBP Regimen Improves Event-Free Survival for Poor Prognosis Patients with Aggressive NHL as Compared to Standard CHOP
Clinical Lymphoma. 2001;1(4):259-260   Crossref logo
Link1 Link2

Outcome following alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant regimen for relapsed and refractory non-Hodgkin’s lymphoma (NHL)
Transfusion and Apheresis Science. 2005;32(1):73-83   Crossref logo
Link1 Link2

Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocols
Pediatric Blood & Cancer. 2008;50(3):633-635   Crossref logo
Link1 Link2

Tositumomab and iodine I 131 tositumomab (BEXXAR® therapeutic regimen) produces long-term durable responses in heavily pretreated patients with relapsed, refractory, and transformed low-grade non-Hodgkin’s lymphoma (NHL
International Journal of Radiation Oncology*Biology*Physics. 2004;60(1):S220   Crossref logo
Link1 Link2

Tositumomab and iodine I 131 tositumomab (BEXXAR® therapeutic regimen) produces long-term durable responses in heavily pretreated patients with relapsed, refractory, and transformed low-grade non-Hodgkin’s lymphoma (NHL
International Journal of Radiation OncologyBiologyPhysics. 2004;60:S220-S220   Crossref logo
Link1 Link2

Weekly polyethylene glycol-conjugated l-asparaginase produces better induction remission rates for children with relapsed acute lymphoblastic leukemia than biweekly dosing
Evidence-based Oncology. 2001;2(1):42-44   Crossref logo
Link1 Link2

CEREBELLAR TOXICITY FOLLOWING HYPERCVAD REGIMEN FOR ACUTE LYMPHOBLASTIC LEUKAEMIA
British Journal of Haematology. 1999;104(3):644-645   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.